SlateStone Wealth’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,668
Closed -$1.85M 299
2024
Q1
$1.85M Sell
5,668
-6,216
-52% -$1.53M 0.19% 101
2023
Q4
$2.27M Buy
11,884
+2
+0% +$378 0.29% 80
2023
Q3
$2.37M Sell
11,882
-9
-0.1% -$2.13K 0.34% 72
2023
Q2
$3.39M Buy
11,891
+39
+0.3% +$10.8K 0.64% 35
2023
Q1
$2.57M Buy
+11,852
New +$2.31M 0.53% 44

Other funds holding SWAV

SlateStone Wealth's SWAV Position: Q2 2024 in Review

SlateStone Wealth sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 5,668 shares — an estimated $1.85M sold.

SlateStone Wealth first reported a position in SWAV in Q1 2023 and held it in 5 quarters. The position peaked at $3.39M in Q2 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • SlateStone Wealth reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • SlateStone Wealth sold 5,668 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $1.85M.
  • SlateStone Wealth first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2023 and held it in 5 quarters.
  • SlateStone Wealth's Shockwave Medical, Inc. Common Stock position peaked at $3.39M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on SlateStone Wealth's 13F filing for Q2 2024, filed 25 Jul 2024.